SCHEDULE: ARK & Wood Confirm 7.3% Stake in Twist Bioscience

ARK Investment Management LLC and Catherine D. Wood have filed an amendment confirming their joint beneficial ownership of 7.31% of Twist Bioscience Corp. common stock as of June 30, 2026.

Summary

• ARK Investment Management LLC and Catherine D. Wood have jointly filed Amendment No. 9 to their Schedule 13G.
• This filing confirms their beneficial ownership of 4,549,803 shares of Twist Bioscience Corp. common stock.
• This ownership stake represents 7.31% of the class of securities.
• The filing is an agreement to jointly file statements regarding their ownership.
• The date of the event requiring this filing was June 30, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily due to the confirmation of significant beneficial ownership and the ongoing investment strategy, without immediate negative indicators.

Positives

• Confirmation of a substantial ownership stake (7.31%) in Twist Bioscience Corp. by ARK Investment Management and Catherine D. Wood.
• The filing indicates a continued and coordinated investment strategy between ARK and Catherine D. Wood.
• The reporting persons are acting in accordance with SEC regulations for joint filings.

Negatives

• No specific negative financial or operational information about Twist Bioscience Corp. is present in this filing, as it pertains to ownership disclosure.
• The filing does not provide details on the rationale behind the ownership level or future intentions beyond continued investment.

Risks

• The filing itself does not introduce new risks to Twist Bioscience Corp.; it is a disclosure of existing ownership.
• Potential future changes in ARK's investment strategy or market conditions could impact their holdings and, consequently, Twist Bioscience's stock.

Future Outlook

The filing does not contain forward-looking statements or specific guidance regarding Twist Bioscience Corp.'s future performance. It solely pertains to the reporting of beneficial ownership.

Management Comments

• ARK Investment Management LLC and Catherine D. Wood agree to file Amendment No. 9 on Schedule 13G relating to their ownership of the Common Stock of the Issuer.
• They further agree that said Amendment No. 9 on Schedule 13G shall be filed on behalf of each of them.

Industry Context

StockSavvy.ai notes that this filing is a routine disclosure under SEC regulations, indicating a significant institutional holding. It does not provide operational insights into Twist Bioscience's business but confirms the sustained interest of a prominent investment firm in the synthetic biology sector.

Stakeholder Impact

• Shareholders: The confirmation of a significant, coordinated stake by ARK and Catherine Wood may be viewed positively, potentially signaling confidence in the company's long-term prospects.
• Management of Twist Bioscience Corp.: The filing acknowledges a substantial investor, which could influence future strategic discussions or board representation considerations.

Next Steps

• ARK Investment Management LLC and Catherine D. Wood will continue to file amendments to Schedule 13G as required by SEC regulations concerning their beneficial ownership of Twist Bioscience Corp. stock.

Key Dates

Keywords

Twist Bioscience, ARK Investment Management, Catherine Wood, Schedule 13G, Beneficial Ownership, Common Stock, Amendment, SEC Filing